Literature DB >> 16722894

Wound bed preparation and a brief history of TIME.

Gregory S Schultz1, David J Barillo, David W Mozingo, Gloria A Chin.   

Abstract

Management of chronic wounds has progressed from merely assessing the status of a wound to understanding the underlying molecular and cellular abnormalities that prevent the wound from healing. The concept of wound bed preparation has simultaneously evolved to provide a systematic approach to removing these barriers to natural healing and enhancing the effects of advanced therapies. This brief review of wound bed preparation traces the development of these concepts and explains how to apply systematic wound management using the TIME acronym - tissue (non viable or deficient), infection/inflammation, moisture (imbalance) and edge (non advancing or undermined).

Entities:  

Mesh:

Year:  2004        PMID: 16722894      PMCID: PMC7951422          DOI: 10.1111/j.1742-481x.2004.00008.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  42 in total

1.  Classifications for wound bed preparation and stimulation of chronic wounds.

Authors:  V Falanga
Journal:  Wound Repair Regen       Date:  2000 Sep-Oct       Impact factor: 3.617

2.  EFFECT OF AIR EXPOSURE AND OCCLUSION ON EXPERIMENTAL HUMAN SKIN WOUNDS.

Authors:  C D HINMAN; H MAIBACH
Journal:  Nature       Date:  1963-10-26       Impact factor: 49.962

Review 3.  Preparing the wound bed--debridement, bacterial balance, and moisture balance.

Authors:  R G Sibbald; D Williamson; H L Orsted; K Campbell; D Keast; D Krasner; D Sibbald
Journal:  Ostomy Wound Manage       Date:  2000-11       Impact factor: 2.629

4.  Occlusive dressings.

Authors:  W H Eaglstein; P M Mertz; V Falanga
Journal:  Am Fam Physician       Date:  1987-03       Impact factor: 3.292

5.  A new primary wound dressing made of polyethylene oxide gel.

Authors:  S H Mandy
Journal:  J Dermatol Surg Oncol       Date:  1983-02

6.  Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity.

Authors:  H Cook; K J Davies; K G Harding; D W Thomas
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

7.  Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1.

Authors:  A Hasan; H Murata; A Falabella; S Ochoa; L Zhou; E Badiavas; V Falanga
Journal:  J Dermatol Sci       Date:  1997-11       Impact factor: 4.563

8.  Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors.

Authors:  A C Stanley; H Y Park; T J Phillips; V Russakovsky; J O Menzoian
Journal:  J Vasc Surg       Date:  1997-12       Impact factor: 4.268

9.  Fibroblasts cultured from venous ulcers display cellular characteristics of senescence.

Authors:  M V Mendez; A Stanley; H Y Park; K Shon; T Phillips; J O Menzoian
Journal:  J Vasc Surg       Date:  1998-11       Impact factor: 4.268

10.  Fibroblast senescence in pressure ulcers.

Authors:  J S Vande Berg; R Rudolph; C Hollan; P L Haywood-Reid
Journal:  Wound Repair Regen       Date:  1998 Jan-Feb       Impact factor: 3.617

View more
  34 in total

1.  The visualisation and speed of kill of wound isolates on a silver alginate dressing.

Authors:  Samuel J Hooper; Steven L Percival; Katja E Hill; David W Thomas; A J Hayes; David W Williams
Journal:  Int Wound J       Date:  2012-03-08       Impact factor: 3.315

2.  Assessing bacterial burden in wounds: comparing clinical observation and wound swabs.

Authors:  Charne Nicole Miller; Keryln Carville; Nelly Newall; Suzanne Kapp; Gill Lewin; Leila Karimi; Nick Santamaria
Journal:  Int Wound J       Date:  2010-11-16       Impact factor: 3.315

Review 3.  The diabetic foot: the importance of biofilms and wound bed preparation.

Authors:  Stephen C Davis; Lisa Martinez; Robert Kirsner
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

4.  Effectiveness of a polyhexanide irrigation solution on methicillin-resistant Staphylococcus aureus biofilms in a porcine wound model.

Authors:  Stephen C Davis; Andrew Harding; Joel Gil; Fernando Parajon; Jose Valdes; Michael Solis; Alex Higa
Journal:  Int Wound J       Date:  2017-03-07       Impact factor: 3.315

5.  How might we achieve oxygen balance in wounds?

Authors:  Paul J Davis
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

Review 6.  A clinical review of infected wound treatment with Vacuum Assisted Closure (V.A.C.) therapy: experience and case series.

Authors:  Allen Gabriel; Jaimie Shores; Brent Bernstein; Jean de Leon; Ravi Kamepalli; Tom Wolvos; Mona M Baharestani; Subhas Gupta
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

Review 7.  Care of chronic wounds in palliative care and end-of-life patients.

Authors:  Christine A Chrisman
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

8.  Assessment and documentation of non-healing, chronic wounds in inpatient health care facilities in the Czech Republic: an evaluation study.

Authors:  Andrea Pokorná; David Leaper
Journal:  Int Wound J       Date:  2014-09-16       Impact factor: 3.315

Review 9.  Wound bed preparation: TIME for an update.

Authors:  Rhiannon L Harries; David C Bosanquet; Keith G Harding
Journal:  Int Wound J       Date:  2016-09       Impact factor: 3.315

10.  Topical steroids for chronic wounds displaying abnormal inflammation.

Authors:  D C Bosanquet; A Rangaraj; A J Richards; A Riddell; V M Saravolac; K G Harding
Journal:  Ann R Coll Surg Engl       Date:  2013-05       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.